| dc.description.abstract | Background: Cardiovascular disease is a disease caused by impaired function of
the heart and blood vessels and is the main cause of death in the world, data from
the World Health Organization (WHO) says cardiovascular disease is included in
the category of non-communicable diseases (PTM) which is the cause of death.
major cause of death and will increase every year.
Aim: This study was to determine the profile of the use of cardiovascular drugs in
outpatients at PKU Muhammadiyah Gamping Hospital during the 2020-2021
period based on the type of drug and the quantity of its use
Methods: This study is a retrospective descriptive study during the years 20202021
which
was
obtained
from
the
Hospital
Management
Information
System
(SIM
RS).
The method used in this study is the quantitative method of Anatomical
Therapeutic Chemical (ATC) / Defined Daily Dose (DDD) and Drug Utilization
90% (DU90%).
Results : The results of the research on cardiovascular drugs used were 26 drugs
during the years 2020-2021. Based on the DU90% profile, cardiovascular drugs that
enter the DU90% segment in outpatients in 2020 are kandesartan, amlodipine,
furosemide, clopidogrel, ramipril, simvastatin, bisoprolol, and acetylsalicylic acid.
In 2021, the DU90% segment includes kandesartan, amlodipine, ramipril,
furosemide, clopidogrel, nifedipine, simvastatin, and bisoprolol.
Conclusion: The most widely used cardiovascular drug in 2020-2021 is
Kandesartan. The average use of cardiovascular drugs in 2020 is 824,569
DDD/1000KPRJ and in 2021 it is 800,165 DDD/1000KPRJ. For the least use of
drugs in 2020, namely diltiazem at 220 DDD/1000 KPRJ, in 2021 the least use is
valsartan 159 DDD/1000 KPRJ. | en_US |
